- Immunotherapy using CAR T-cells2015 | Faculty of Medicine in Pilsen
- CAR T cell therapy in lymphoma treatment2018 | First Faculty of Medicine
- Enzymatically produced piggyBac transposon vectors for efficient non-viral manufacturing of CD19-specific CAR T cells2021 | Central Library of Charles University, Faculty of Science
- Relapsing / refractory pediatric ALL: allogeneic SCT or CAR-T cells?2021 | Second Faculty of Medicine
- A new approach to CAR T-cell gene engineering and cultivation using piggyBac transposon in the presence of IL-4, IL-7 and IL-212018 | First Faculty of Medicine, Central Library of Charles University
- Characterization of the input material quality for the production of tisagenlecleucel by multiparameter flow cytometry and its relation to the clinical outcome2023 | First Faculty of Medicine, Second Faculty of Medicine, Faculty of Science
- Characterization of the input material quality for the production of tisagenlecleucel by multiparameter flow cytometry and its relation to the clinical outcome2023 | Faculty of Science
- Chimeric Antigen Receptor Based Cellular Therapy for Treatment Of T-Cell Malignancies2022 | First Faculty of Medicine
- Trial Watch: Immunostimulation with recombinant cytokines for cancer therapy2018 | Second Faculty of Medicine
- Immune modulation via T regulatory cell enhancement: Disease-modifying therapies for autoimmunity and their potential for chronic allergic and inflammatory diseases-An EAACI position paper of the Task Force on Immunopharmacology (TIPCO)2021 | First Faculty of Medicine
- Catching Them Early: Framework Parameters and Progress for Prenatal and Childhood Application of Advanced Therapies2022 | Faculty of Pharmacy in Hradec Králové
- Current Immunotherapy Approaches in Non-Hodgkin Lymphomas2020 | First Faculty of Medicine
- Cellular therapy with axicabtagene ciloleucel2021 | Publication without faculty affiliation
- Trial watch: Peptide-based vaccines in anticancer therapy2018 | Second Faculty of Medicine
- Trial watch: chemotherapy-induced immunogenic cell death in oncology2023 | Second Faculty of Medicine
- Trial watch: chemotherapy-induced immunogenic cell death in immuno-oncology2020 | Second Faculty of Medicine
- Natural killer cell-based strategies for immunotherapy of cancer2022 | Faculty of Science
- Inducible secretion of IL-21 augments anti-tumor activity of piggyBac-manufactured chimeric antigen receptor T cells2020 | First Faculty of Medicine, Faculty of Science
- Advances in the development of anti-cancer vaccines2018 | Second Faculty of Medicine
- The Role of Cryopreservation Techniques in Manufacturing, Transport, and Storage of Car-T Therapy Products2023 | Faculty of Medicine in Hradec Králové
- Lenalidomide enhances antitumor functions of chimeric antigen receptor modified T cells2016 | First Faculty of Medicine
- CAR-T treatment in oncology CAR-T treatment in onkology and hematooncology2019 | Publication without faculty affiliation
- Multiple myeloma - are we in 2020 able to cure the patient?2020 | First Faculty of Medicine
- CD19 expression in pediatric patients with relapsed/refractory B-cell precursor acute lymphoblastic leukemia pre- and post-treatment with blinatumomab2021 | Second Faculty of Medicine
- Allogeneic hematopoietic cell transplantation and cellular therapy in CLL2019 | First Faculty of Medicine
- CD19-negative relapse of pediatric B-cell precursor acute lymphoblastic leukemia following blinatumomab treatment2017 | Second Faculty of Medicine
- New trends in the multiple myeloma treatment2019 | First Faculty of Medicine
- Targeting fibroblast activation protein in cancer - Prospects and caveats2018 | First Faculty of Medicine
- The Use of the LanthaScreen TR-FRET CAR Coactivator Assay in the Characterization of Constitutive Androstane Receptor (CAR) Inverse Agonists2015 | Faculty of Pharmacy in Hradec Králové
- Emerging glyco-based strategies to steer immune responses2021 | Faculty of Science